Wednesday, July 1, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

ZSQR — Z Squared Inc. SEC Filings | FilingIndex

ZSQRNasdaq

Z Squared Inc.

Finance Services · DE · CIK 1759186

Coeptis Therapeutics develops cell therapies for diseases and uses AI and RPA for operational enhancement

red 8-K · 90d

+ Watch View on EDGAR ↗

$562M

Market cap

$10.58

Last close

-9.3%

1D

-20.9%

5D

615K

Volume

Price · last 40 sessions-24.9%

May 4L $8.16 · H $16.73Jun 30

141

Total filings

Jun 30, 2026

Last filing

12/31

Fiscal year end

All 8-K · 58 10-Q · 17 SC 13G · 14 S-1/A · 10 S-1 · 6 10-K · 6 10-Q/A · 5 10-K/A · 5

8-KExecutive Change · Reg FD DisclosureJun 30, 2026 8-KReg FD Disclosure · Company UpdateJun 29, 2026 8-KMaterial Agreement · Reg FD DisclosureJun 26, 2026 8-KMaterial Agreement · Equity IssuanceJun 4, 2026 8-KExecutive ChangeMay 22, 2026 8-K

Similar companies

Comparable business profile · signals at a glance

CBIOCRESCENT BIOPHARMA, INC.$494.1M0.0%SLSSELLAS Life Sciences Group, Inc.$1.5B-4.5%CHRSCoherus Oncology, Inc.$215.9M-3.5%IPSCCentury Therapeutics, Inc.$405.8M+1.7%CGENCOMPUGEN LTD

Reg FD Disclosure

May 21, 2026

8-KExecutive Change · Material AgreementMay 1, 2026

8-KChange of Control · Executive ChangeApr 30, 2026

8-KCompany UpdateApr 28, 2026

8-KReg FD DisclosureApr 24, 2026

8-KCompany UpdateApr 8, 2026

8-KExecutive Change · Company UpdateFeb 12, 2026

8-KShareholder VoteFeb 4, 2026

8-KDelisting NoticeJan 16, 2026

8-KMaterial Agreement · Reg FD DisclosureApr 28, 2025

8-KExecutive ChangeMar 27, 2025

8-KMaterial Agreement · Equity IssuanceJan 24, 2025

8-KCompany UpdateJan 22, 2025

8-KBylaw Amendment · Company UpdateDec 27, 2024

8-KShareholder VoteDec 20, 2024

8-KCompany UpdateDec 17, 2024

8-KCompany UpdateDec 4, 2024

8-KMaterial AgreementNov 6, 2024

8-KAuditor ChangeSep 30, 2024

8-KDelisting Notice · Company UpdateSep 19, 2024

8-KRestatementAug 14, 2024

8-KDelisting NoticeJul 31, 2024

8-KExecutive Change · Equity IssuanceJun 20, 2024

8-KRestatementMar 25, 2024

8-KDelisting Notice · Company UpdateFeb 1, 2024

8-KShareholder VoteDec 22, 2023

8-KReg FD DisclosureDec 5, 2023

8-KMaterial Agreement · Equity IssuanceOct 27, 2023

8-KEquity IssuanceOct 13, 2023

8-KDelisting NoticeAug 30, 2023

8-KMaterial Agreement · Acquisition / DispositionAug 22, 2023

8-KMaterial Agreement · Company UpdateJun 16, 2023

8-KDelisting Notice · Company UpdateJun 9, 2023

8-KReg FD DisclosureJun 6, 2023

8-KExecutive Change · Company UpdateMay 17, 2023

8-KCompany UpdateJan 31, 2023

8-KDelisting NoticeDec 29, 2022

8-KChange of Control · Executive ChangeNov 3, 2022

8-KShareholder VoteOct 26, 2022

8-KReg FD DisclosureJul 6, 2022

8-KMaterial Agreement · New Debt / ObligationMay 20, 2022

8-KMaterial Agreement · New Debt / ObligationMay 3, 2022

8-KBylaw Amendment · Shareholder VoteApr 27, 2022

8-KMaterial Agreement · Reg FD DisclosureApr 19, 2022

8-KShareholder VoteDec 20, 2021

8-KRestatementNov 16, 2021

8-KCompany UpdateOct 22, 2021

8-KDelisting Notice · Company UpdateSep 3, 2021

8-KDelisting Notice · Company UpdateMay 28, 2021

8-KRestatementMay 14, 2021

8-KCompany UpdateDec 15, 2020

8-KCompany UpdateNov 9, 2020

8-KMaterial Agreement · Equity IssuanceNov 3, 2020

$193.0M

-0.9%

CRBUCaribou Biosciences, Inc.$158.2M-0.6%